Drug Regulatory Bodies Advise Market Withdrawal of Tavneos Following Findings of Data Tampering The drug regulatory bodies of the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have advised the removal of Tavneos (avacopan) from the market. This recommendation comes after the findings of an independent investigation conducted earlier this year, […]
Read More